Survival after hepatic resection for colorectal metastases: a 10-year experience.
about
Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trialRadiotherapy for Colorectal Cancer: Current Standards and Future PerspectivesColorectal cancer: Metastases to a single organStereotactic body radiation therapy for liver metastasesThe role of local ablative therapy in oligometastatic non-small-cell lung cancer: hype or hope.Selection for hepatic resection of colorectal liver metastases: expert consensus statementNear-infrared fluorescence-guided resection of colorectal liver metastasesInteraction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases.Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastasesMetastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapySurgical management of colorectal cancer metastases to the liver: multimodality approach and a single institutional experience.Identification of prognostic inflammatory factors in colorectal liver metastases.Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone?Early and long-term outcomes of patients undergoing liver resection and diaphragm excision for advanced colorectal liver metastases.Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature.Utility of preoperative imaging in evaluating colorectal liver metastases declines over time.Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinomaCan the National Health Service Cancer Plan timeline be applied to colorectal hepatic metastases?Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors.Evaluation of the introduction of a standardised protocol for the staging and follow-up of colorectal cancer on resection rates for liver metastases.Near-infrared fluorescence imaging of liver metastases in rats using indocyanine green.Inferior vena cava resection with hepatectomy: challenging but justified.Colorectal liver metastasesOutcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatmentMulticenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study.B7-H1 expression is associated with expansion of regulatory T cells in colorectal carcinoma.Multicentre results of stereotactic body radiotherapy for secondary liver tumours.Synchronous Resectable Metastatic Colorectal Cancer: Lymph Node Involvement Predicts Poor Outcome.Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III TrialAssessing the management of hepatic colorectal cancer metastases: is treatment consistent in Ontario?Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention.Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agentsPredictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.Ablative Therapies in Metastatic Breast Cancer: A Systematic Review.Recent trends in liver resection surgery activity and population utilization rates in English regions.Preoperative CT versus diffusion weighted magnetic resonance imaging of the liver in patients with rectal cancer; a prospective randomized trial.Comparison of Hepatic Resection and Radiofrequency Ablation for the Treatment of Colorectal Liver Metastasis.Colorectal liver metastases: disappearing lesions in the era of Eovist hepatobiliary magnetic resonance imaging.Factors affecting surgical margin recurrence after hepatectomy for colorectal liver metastasesParenchyma-Sparing Hepatectomy with Vascular Reconstruction Techniques for Resection of Colorectal Liver Metastases with Major Vascular Invasion.
P2860
Q21260391-720B1355-A850-48AF-8F6E-06C576ECF332Q26738806-402A532F-DDB9-4328-86A6-7071F7661714Q26778009-1B7714B7-4B95-43AB-88FB-C452147DF56BQ27008308-E03A2205-063A-4E13-A778-6907A5D95E02Q30248748-038865C2-1C35-40C3-85E7-0ABCF51124F5Q30415026-2EAD36B1-490C-4248-8D6D-B82FBBE1E806Q30544936-0FC01254-C18C-401E-8789-2B73B0DC558CQ33679628-DBA8C53B-D9A1-42FB-8D7E-E777A51B492FQ33713800-C4605317-89B3-42B6-AC13-B7EBC7A0DFB3Q33850248-873D58F0-03C2-44A0-AEDA-C29743BFFACAQ34013522-6F1120B9-33F2-4032-852A-4911379640D2Q34017917-10003C60-BA6E-48C9-A133-70D2B657B1F4Q34207776-F44E2E09-EB57-43EF-A710-FD4317D3CA39Q34251792-E883BCBA-9D1F-4E21-8D4A-17E563E858EDQ34294365-158BEA49-C7E3-4C0B-B37B-552C6F47E785Q34394440-864D3D7F-4826-44A0-B37C-FB1825980141Q34503734-E4CC7D87-6C13-4CC0-8F75-2C519442EE0CQ34512029-6C181003-5634-4EB4-AAAA-A1D45423EB1BQ34645408-1D106231-00F3-4854-AA02-0C8A61BFBCEAQ34822951-3B8BE6EF-584B-495F-9187-26569A5D2194Q35112672-29D86915-DB14-4846-84DE-6F4DCB7DACA6Q35613924-6CFE36F2-61B5-4D95-8D03-4767C80FE6C6Q35687594-6866CA76-E4C1-4461-8DD3-92C27A6CFA76Q35753615-3DDD24DD-5FD5-43A6-A6A4-97E1AEA46319Q35807573-2591A735-E506-439B-8A1B-D329CAC007B0Q35813519-7E1A258F-516B-499E-9BE1-1D39C1856FA6Q35854741-0971D6F5-F682-4A3C-9694-0B85F73B689FQ36009386-30801136-B716-4CAD-ADFB-04CAEA4CB8B3Q36054226-AE43183E-B37D-434D-8805-76BCBA4A3533Q36063326-D2DAC5EC-25BB-4F95-A73C-66EDBFDAC86BQ36324566-1DF74625-F656-4233-8F22-91C69A2C4158Q36343047-79D246FF-F215-4EEE-AF23-96E3B0DF2FFEQ36344123-9349A4BE-C195-4D08-9CAB-EEE399D385C9Q36344204-CF1FCA2A-F118-4467-BE8E-DB0D38EEEA54Q36408408-A9CD3868-120F-4D5E-ADB0-5404A0A051EBQ36469607-03D2358D-85C5-40C7-B624-655ECE9D2B44Q36643526-8AA2CDB9-C9C2-43EA-A7F4-301F90DFEB00Q36747357-C8018D06-89DF-42B8-8016-C1AD1EC7B3ACQ36945965-CE09E5F2-385E-4A58-BC48-7E551EF4CB3FQ37280379-21044802-BD44-4A73-A4F9-AC31883E3357
P2860
Survival after hepatic resection for colorectal metastases: a 10-year experience.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Survival after hepatic resection for colorectal metastases: a 10-year experience.
@ast
Survival after hepatic resection for colorectal metastases: a 10-year experience.
@en
type
label
Survival after hepatic resection for colorectal metastases: a 10-year experience.
@ast
Survival after hepatic resection for colorectal metastases: a 10-year experience.
@en
prefLabel
Survival after hepatic resection for colorectal metastases: a 10-year experience.
@ast
Survival after hepatic resection for colorectal metastases: a 10-year experience.
@en
P2093
P356
P1476
Survival after hepatic resection for colorectal metastases: a 10-year experience.
@en
P2093
Alice C Wei
Bernard Langer
Bryce Taylor
David Grant
Paul D Greig
P2888
P304
P356
10.1245/ASO.2006.05.039
P577
2006-03-10T00:00:00Z
P6179
1035845557